Feature Report：Contributing to Society through Healthcare
A cerebral aneurysm is a localized dilation or ballooning of the blood vessel in a cerebral artery. The rupturing of a cerebral aneurysm can lead to a life-threatening subarachnoid cerebral hemorrhage or intracerebral hemorrhage. One way to treat a cerebral aneurysm is to perform a craniotomy to clip the root of the aneurysm and block the blood flow. Another treatment is a neuroendovascular therapy in which a platinum coil is deployed inside the aneurysm via a catheter.
In Europe and North America, catheter-based neuroendovascular therapies are used in over 50% of all treatments of cerebral aneurysm. The percentage in Japan is about 30% at present but this neuroendovascular therapy is likely to increase in the future as it reduces the physical strain on patients and does not require a lengthy hospitalization.
Terumo's Innovative Technologies Are Helping Many Patients
The treatment of cerebrovascular diseases with neurointerventional techniques has been developing and improving at an unbelievable pace, most notably in the last decade with the impact of endovascular technologies. These new techniques have allowed us to perform less invasive non-surgical procedures.
Terumo Group company, Microvention has been highly involved in the R&D of new devices that have had a great impact on these evolutionary endovascular tools, which ultimately help our patients. I strongly believe that Microvention will continue to play a major role in developing new technologies that will expand the field of stroke treatments.